Beijing Tiantan Biological Products Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000WF9
CNY
17.00
-0.13 (-0.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,774.00
1,304.53
1,939.13
1,219.59
1,602.53
1,209.66
1,148.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,774.00
1,304.53
1,939.13
1,219.59
1,602.53
1,209.66
1,148.84
Raw Material Cost
1,007.88
736.18
935.06
582.32
741.46
555.36
540.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.93
2.40
1.31
1.26
1.35
1.20
0.00
Selling and Distribution Expenses
134.74
152.66
136.27
99.19
169.42
148.53
198.76
Other Expenses
2.15
2.47
3.96
2.53
3.97
1.98
7.93
Total Expenditure (Excl Depreciation)
1,166.10
915.98
1,112.20
708.03
951.91
724.85
818.05
Operating Profit (PBDIT) excl Other Income
607.9
388.5
826.9
511.59999999999997
650.6
484.79999999999995
330.79999999999995
Other Income
28.17
21.88
48.61
25.51
24.45
32.85
28.55
Operating Profit (PBDIT)
747.65
522.31
918.68
629.92
760.17
602.09
434.57
Interest
1.93
2.40
1.31
1.26
1.35
1.20
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
766.13
568.35
1,004.07
637.28
861.06
654.30
608.83
Depreciation
113.63
113.63
94.59
94.59
84.67
84.67
77.02
Profit Before Tax
632.09
406.28
822.78
534.07
674.14
516.22
357.55
Tax
103.57
69.00
137.91
92.13
120.81
84.10
55.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
388.42
244.15
497.45
325.63
409.41
316.67
222.49
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
388.42
244.15
497.45
325.63
409.41
316.67
222.49
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
140.10
93.14
187.43
116.30
143.92
115.45
79.35
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
528.52
337.28
684.87
441.93
553.33
432.13
301.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,573.53
11,382.85
11,138.70
10,641.26
10,315.63
10,139.25
9,822.58
Earnings per share (EPS)
0.2
0.12
0.25
0.16
0.21
0.16
0.11
Diluted Earnings per share
0.2
0.12
0.25
0.16
0.21
0.16
0.11
Operating Profit Margin (Excl OI)
34.15%
29.65%
39.99%
41.8%
40.63%
40.06%
28.64%
Gross Profit Margin
42.04%
39.85%
47.31%
51.55%
47.35%
49.67%
37.83%
PAT Margin
21.89%
18.72%
25.65%
26.7%
25.55%
26.18%
19.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 35.99% vs -32.73% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 56.69% vs -50.75% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 43.78% vs -42.49% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -20.83% vs 84.62% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Beijing Tiantan Biological Products Corp. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,774.00
0
1,774.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,774.00
0
1,774.00
Raw Material Cost
1,007.88
0
1,007.88
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.93
0
1.93
Selling and Distribution Expenses
134.74
0
134.74
Other Expenses
2.15
0.00
2.15
Total Expenditure (Excl Depreciation)
1,166.10
0
1,166.10
Operating Profit (PBDIT) excl Other Income
607.91
0.00
607.91
Other Income
28.17
0
28.17
Operating Profit (PBDIT)
747.65
0
747.65
Interest
1.93
0
1.93
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
766.13
0
766.13
Depreciation
113.63
0
113.63
Profit Before Tax
632.09
0
632.09
Tax
103.57
0
103.57
Provisions and contingencies
0
0
0.00
Profit After Tax
388.42
0
388.42
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
388.42
0
388.42
Share in Profit of Associates
0
0
0.00
Minority Interest
140.10
0
140.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
528.52
0
528.52
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,573.53
0
11,573.53
Earnings per share (EPS)
0.20
0
0.20
Diluted Earnings per share
0.20
0
0.20
Operating Profit Margin (Excl OI)
34.15%
0%
0.00
34.15%
Gross Profit Margin
42.04%
0%
0.00
42.04%
PAT Margin
21.89%
0%
0.00
21.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 177.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 35.99% vs -32.73% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.70% vs 15.81% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 52.85 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 56.69% vs -50.75% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -4.48% vs 33.26% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 71.95 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 43.78% vs -42.49% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.20% vs 34.03% in Jun 2024

Quarterly - Interest
Interest 0.19 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -20.83% vs 84.62% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 35.71% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.15%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024